U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H31N3O3
Molecular Weight 385.4998
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BMY-7378 FREE BASE

SMILES

COC1=CC=CC=C1N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2

InChI

InChIKey=AYYCFGDXLUPJAQ-UHFFFAOYSA-N
InChI=1S/C22H31N3O3/c1-28-19-7-3-2-6-18(19)24-13-10-23(11-14-24)12-15-25-20(26)16-22(17-21(25)27)8-4-5-9-22/h2-3,6-7H,4-5,8-17H2,1H3

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/1970304

BMY-7378 is a multi-targeted inhibitor of α2C-adrenoceptor and α1D-adrenoceptor with pKi of 6.54 and 8.2, respectively, and acts as a mixed agonist and antagonist for 5-HT1A receptor with pKi of 8.3. BMY-7378 was at the preclinical stage of development for the treatment of anxiety disorders, but later was discontinued.

CNS Activity

Originator

Curator's Comment: # Bristol-Myers Squibb

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
1997
Characterization of alpha1-adrenoceptor-mediated contraction in the mouse thoracic aorta.
2001 Jul 20
The hypotensive effect of BMY 7378 is antagonized by a silent 5-HT(1A) receptor antagonist: comparison with 8-hydroxy-dipropylamino tetralin.
2001 Sep-Oct
alpha(1A)-adrenoceptors mediate sympathetically evoked pupillary dilation in rats.
2002 Feb
5-HT1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain.
2002 Oct 4
Interaction between neuropeptide Y Y1 receptors and alpha1B-adrenoceptors in the neurovascular junction of canine splenic arteries.
2003 Apr 18
Evidence for the role of alpha1D- and alpha1A-adrenoceptors in contraction of the rat mesenteric artery.
2003 Feb
Cytosolic Ca2+ and phosphoinositide hydrolysis linked to constitutively active alpha 1D-adrenoceptors in vascular smooth muscle.
2003 Jun
Chromatography studies on bio-affinity of nine ligands of alpha1-adrenoceptor to alpha1D subtypes overexpressed in cell membrane.
2004 Aug
Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation.
2004 Oct
Effects of alpha1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells.
2006 Nov
Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed.
2007 Jul
Inhibitory effect of fentanyl on phenylephrine-induced contraction of the rat aorta.
2009 Jun 30
Patents

Sample Use Guides

Rats: BMY-7378 dose dependently (0.25-5 mg/kg s.c.) reduces the undetectable levels forepaw treading and head weaving induced by 8-OH-DPAT (0.75 mg/kg s.c.) in rats.
Route of Administration: Other
In Vitro Use Guide
BMY-7378 at concentration of 1 nM to 30 nM elicits inhibitory effects in a concentration-dependent manner in the rat dorsal raphe nucleus.
Name Type Language
BMY-7378 FREE BASE
Common Name English
8-AZASPIRO(4.5)DECANE-7,9-DIONE, 8-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-
Systematic Name English
Code System Code Type Description
FDA UNII
08EI0K81OL
Created by admin on Fri Dec 15 18:41:40 GMT 2023 , Edited by admin on Fri Dec 15 18:41:40 GMT 2023
PRIMARY
EPA CompTox
DTXSID70943430
Created by admin on Fri Dec 15 18:41:40 GMT 2023 , Edited by admin on Fri Dec 15 18:41:40 GMT 2023
PRIMARY
PUBCHEM
2419
Created by admin on Fri Dec 15 18:41:40 GMT 2023 , Edited by admin on Fri Dec 15 18:41:40 GMT 2023
PRIMARY
CAS
21102-94-3
Created by admin on Fri Dec 15 18:41:40 GMT 2023 , Edited by admin on Fri Dec 15 18:41:40 GMT 2023
PRIMARY